Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Intravenous Oseltamivir in Patients Aged ≥13 Years With Influenza
2010-020083-38Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of oseltamivir in influenza and H1N1 influenza (H1N1), sponsored by Roche. Primary endpoint: Safety (adverse events, labs, vital signs, ECG). Started Jul 2010; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenzaH1N1 influenza (H1N1)
Beyond the preview
Go deeper on 2010-020083-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020083-38.